RARE DISEASES A–Z · LETTER M

Multiple System Atrophy

Multiple system atrophy (MSA) is a rare, progressive brain disease in which several systems fail together — movement, balance, and above all the autonomic nervous system that runs blood pressure, bladder, and other automatic functions. It is one of the 'atypical parkinsonian' disorders, and it moves faster than Parkinson disease.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.

In short: Multiple system atrophy is a rapidly progressive alpha-synuclein disease combining parkinsonism, imbalance, and severe autonomic failure — blood pressure and bladder above all. No treatment slows it; expert multidisciplinary symptom care is the mainstay.

The guide

The basics

Alpha-synuclein — the same protein that clumps in Parkinson disease — accumulates in MSA mainly inside oligodendrocytes, the support cells that insulate nerve fibres. Three systems fail in varying proportions: the autonomic system (blood pressure control collapses, so standing causes faintness; the bladder fails to empty or becomes overactive; erectile dysfunction is often the earliest symptom in men), the parkinsonian system (stiffness, slowness, tremor that is jerky rather than resting, early falls), and the cerebellar system (imbalance, slurred scanning speech, clumsy limbs). Sleep is disrupted — many people act out their dreams years beforehand. MSA usually begins in the 50s or 60s and progresses faster than Parkinson disease, with survival typically measured in years from onset rather than decades.

How it works

There is no single test; diagnosis is clinical, using international criteria that weigh autonomic failure plus parkinsonism or cerebellar signs. MRI can support it — characteristic changes include shrinkage of the pons and cerebellum (with a 'hot cross bun' pattern) and changes in the putamen — and specialised scans help distinguish MSA from Parkinson disease and progressive supranuclear palsy, its main mimics. Formal autonomic testing (tilt-table blood pressure measurements, bladder studies) documents the failure objectively. A poor or short-lived response to levodopa is itself a diagnostic clue. Because early MSA is frequently misdiagnosed as Parkinson disease, the diagnosis is often revised as features declare themselves — a frustrating but well-recognised path.

Day to day

No treatment slows MSA, so care is systematic symptom management. Levodopa helps a minority, partially and temporarily, and is usually trialled. Standing blood pressure is managed with increased salt and fluids (when safe), compression garments, head-up sleeping, and medicines that raise pressure or prevent its post-meal fall. Bladder problems are managed with medicines, intermittent self-catheterisation, or a suprapubic catheter when emptying fails. Physiotherapy maintains mobility and prevents falls; speech therapy monitors the swallow and communication; dietitians guard nutrition. Stridor — noisy breathing from vocal cord dysfunction — may need CPAP at night or, rarely, tracheostomy. Constipation, mood, and sleep disturbance are each treated actively.

When to get help

Care is multidisciplinary from the start: neurology, autonomic specialists, urology, speech and swallowing therapy, physiotherapy, dietetics, and palliative care for planning and symptom control — early involvement improves quality of life and is not only for the end of life. Reviews track blood pressure lying and standing, bladder function, swallowing, weight, sleep breathing (stridor needs urgent assessment), and mood. Driving and work decisions are revisited as mobility changes. Seek prompt help for choking, chest infection, urinary retention, falls with injury, or fainting. Advance care planning — recording preferences while communication is easy — is strongly encouraged and genuinely helps families later.

See a doctor promptly if: Noisy breathing (stridor), choking episodes, a chest infection, or fainting with injury in someone with MSA needs prompt — for breathing difficulty, emergency — assessment.

Common questions

How is MSA different from Parkinson's disease?

Both involve parkinsonism, but MSA adds early, severe autonomic failure (blood pressure collapse on standing, bladder failure) and often cerebellar imbalance, progresses faster, and responds poorly to levodopa. Pathology also differs: in MSA the alpha-synuclein clumps are mainly in support cells (glia) rather than neurons.

Is multiple system atrophy inherited?

Most cases appear to arise by chance (sporadic), and no strong inherited pattern has been found for typical MSA, despite the alpha-synuclein link with Parkinson disease. A genetic form has been reported in a few families, but it is exceptional — relatives are not usually offered testing.

How long do people live with MSA?

Average survival after symptoms begin is around six to ten years, though the range is wide and care quality changes the trajectory. The greatest risks are complications — chest infections, choking, falls, and sudden drops in blood pressure — which good multidisciplinary care works to prevent.

What is stridor, and why does it matter?

A harsh, high-pitched breathing noise caused by vocal cord dysfunction. It is a red flag in MSA: it needs prompt assessment because the airway can narrow dangerously, particularly during sleep, and treatments (including CPAP or occasionally tracheostomy) are available.

More in Letter M

Related

This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Blood pressure, bladder, and mobility management are individual; follow your neurology team's plan.